Watch · Quality 31/100
Simple research view
BSX · Boston Scientific Corporation
$44.20 latest stored close
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$BSX
Boston Scientific CorporationBoston Scientific Corporation is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $66B.
Council read · 6 methods
Watch — evidence is building
0 buyable · 3 watch · 3 avoid. Review the observed passes and blockers before reading the chart.
Earnings-risk mode
Pre-earnings setup
Wednesday, July 29, 2026
Time not confirmed
No sourced report session or clock time
Ordinary position sizing suppressed.
Earnings are less than three full trading sessions away; treat the gap as event risk, not ordinary stop-distance risk.
Deterministic evidence
BSX-0.58%
CatalystUnavailable
Stock reactionNegative
Sector reactionUnavailable
Opening surgeUnavailable
Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.
AI interpretation (optional)
Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.
Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.BSX Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Setup Quality
D
0/7 signals
✗
Stage 4 · Declining
✗
Power Trend
✗ RS New High
✗ Trend 0/8
✗
No Pattern
✗ CANSLIM 45.7 (D)
✗ Gatekeeper
Base #1 (A)
Technical Analysis Report Card
$BSX · $44.20 · as of 2026-06-25 · multi-factor read
12
/ 100
Trend · Daily / Weekly / Monthly
Daily
▼ Downtrend
Weekly
▼ Downtrend
Monthly
▼ Downtrend
Moving Averages
50-day$53.49 ↓
100-day$62.38 ↓
200-day$79.94 ↓
Bearish (50 < 200)
RSI (14)
Reading29.1 · Oversold
Oversold — sellers extended; a relief bounce is possible.
MACD (12/26/9)
StateImproving
Histogram+0.052
Improving — MACD crossed above its signal line but still below zero. Histogram expanding.
Bollinger Bands (20,2)
%B / Width8% · 14.2%
Near the lower band — under pressure or oversold.
Volume · Buyer vs Seller
Up/Down vol0.31 · Distribution
Rel volume0.96×
Distribution — volume is concentrated on down days; sellers dominate. Recent volume is easing versus its baseline.
Support & Resistance
R · $50.14swing level
R · $58.34swing level
R · $66.88swing level
Price · $44.20now
S · $43.8952-week low
Fibonacci · Downtrend swing
23.6%$57.34
38.2%$65.67
50.0%$72.40
61.8%$79.12
78.6%$88.70
Retracement resistance zones measured from the recent swing high down to the low.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for BSX — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Daily downtrendWeekly downtrendMonthly downtrendBelow 200-day MA50/200 bearishRSI oversold
Want this read in a legend's voice?
💬 Ask a Legend about BSX
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
🟡 3 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini D
Trend-template read: fails Price > 200-day MA (MA150 not stored).
Passing evidence
4. Not extended (≤5% above pivot)Measured as passing
4. Stop within 7–8% of entryMeasured as passing
Failing evidence
1.1 Price > 200-day MA (MA150 not stored)Price $44.20, MA200 $79.94
1.4 50-day MA > 200-day MA (MA150 not stored)MA50 $53.49, MA200 $79.94
Avoid
O'Neil D
CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
S: Base tightness (ATR% ≤ 4.5%)ATR% 3.30%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+0.0% QoQ
L: RS rank ≥ 80Data unavailable
Avoid
Weinstein D
Stage-analysis read: declining (Stage 4) is not an advancing Stage 2.
Passing evidence
No passing evidence available.
Failing evidence
Stage 2 (Advancing phase) confirmedStage 4 (Declining)
Price above 30-week MA (200-day proxy)Price $44.20 vs MA200 $79.94
Watch
Livermore C
Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$44.20
Detected patternFlat Base
Failing evidence
Volume vs average0.96x
Distance from 52-week high59.6% below high
Watch
Darvas C
Box-theory read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$44.20
Detected patternFlat Base
Failing evidence
Volume vs average0.96x
Distance from 52-week high59.6% below high
Watch
Wyckoff C
Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$44.20
Detected patternFlat Base
Failing evidence
Volume vs average0.96x
Distance from 52-week high59.6% below high
Breakout Health
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
🕯 Latest candle: Doji — Open and close nearly equal — indecision. After a strong move it can signal a pause or pending reversal; wait for confirmation.
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▼ Falling
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net -3
Fundamentals & leadership quality — Minervini SEPA criteria · 1/7 met
D
1/7 SEPA
Separate score from the 8-point Trend Template (0/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+0%
Revenue growth ≥20% YoY
+20%
Gross margin ≥30%
69%
ROE ≥17%
15%
RS rating ≥80 (leadership)
0
Stage 2 uptrend (Weinstein)
Stage 4
Within 25% of 52W high
-59.6%
Method Playbook
📋 Trade it like Weinstein
EXACT LEVELS · PRO
Weinstein D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro levelPublished-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis (historical · 30d ago)
Flat Base
⚠ Not actionable yet
31.3
score
RS Score
0
Trend
0/8 ✗
CANSLIM
45.7* (D)
depth pct: 6.8
base days: 35
prior uptrend pct: 26.7
weekly close spread pct: 4.8
vol dried: ✓
validation reason: valid generic setup
multi tf reason: weekly trend template 0/8 — not confirmed (needs ≥4/8)
Why This Setup?
Flat Base
Flat Base: 35d base, depth 6.8%, prior uptrend 27%. Pivot $108.94. | Weak trend (0/8) | High-confidence pattern (85%) | Readiness 41/100 (early) | CANSLIM 45.7 (D) | ⚠ Not actionable yet
The Universal Edge Check
The panel is uneasy
Too many universals unmet — this leans closer to a guess than a trade.
0/7
universals met
- In a confirmed uptrend Trend 0/8 — no uptrend; don't bottom-fish
- Risk is defined No stop — undefined risk
- Asymmetric reward No target set
- Not chasing (in range) Pivot distance unknown
- Volume confirms 1.0× average — light
- Clear of earnings in 1 days — event risk
- A relative-strength leader RS unknown
Minervini Trend Template
0/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$44.20 vs SMA150 $73.39 / SMA200 $79.94
SMA 150 above SMA 200
SMA150 $73.39 vs SMA200 $79.94
SMA 200 trending up
Slope -5.82 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $53.49
Price above SMA 50
$44.20 vs SMA50 $53.49
30%+ above 52W low
+0.7% from $43.89
Within 25% of 52W high
-59.6% from $109.50
RS score above 70
RS 0
Fundamentals
52W Range
0%
Mkt Cap SEC
65.7B
EPS QoQ
0%
Rev YoY
+20%
ROE
15%
Gross Margin
69%
D/E
0.47
EPS TTM
$1.94
P/E TTM
22.8x
Float
1.5B
Insider
No Buy
Company
Legend AI snapshot
Boston Scientific Corporation
$44.20latest close
$65.7Bmarket cap
0RS rank
31setup score
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
D
45.7* CANSLIM
* disqualified on C, M
C · Curr. EPS
55
A · Annual EPS
76
N · New Highs
40
S · Supply/Demand
80
L · Leader RS
0
I · Inst. Spons.
96
M · Market
0
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
0/8
W. RS
25
W. Support
$43.89
W. Resist
$100.90
Weekly Structure
Trend
Falling
Tight Weeks
0
Confirmation
Bearish
Get the full picture on BSX
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.
Start 7-Day Free Trial